Procaps Group, S.A. - stock earnings
PROC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 8.2 million USD | 118.4 million USD |
| 2023Q2 | 8.2 million USD | 118.4 million USD |
| 2023Q1 | 10.4 million USD | 101.5 million USD |
| 2022Q4 | 10.4 million USD | 101.5 million USD |
| 2022Q3 | 22.6 million USD | 110.4 million USD |
| 2022Q2 | -6.9 million USD | 112.4 million USD |
| 2022Q1 | -46.3 million USD | 126.5 million USD |
| 2021Q4 | -46.3 million USD | 126.5 million USD |
| 2021Q3 | -36.6 million USD | 106.8 million USD |
| 2021Q2 | -649000 USD | 98.9 million USD |
| 2021Q1 | -17.3 million USD | 77.4 million USD |
| 2020Q4 | 9.4 million USD | 118.1 million USD |
| 2020Q3 | -969000 USD | 79.3 million USD |
| 2020Q2 | 8.7 million USD | 81.9 million USD |
| 2020Q1 | -27.6 million USD | 52.1 million USD |
| 2019Q4 | -4.3 million USD | 81.2 million USD |
| 2019Q3 | -4.3 million USD | 81.2 million USD |
| 2019Q2 | -4.3 million USD | 81.2 million USD |
| 2019Q1 | -4.3 million USD | 81.2 million USD |
PROC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 52.2 million USD | 414.1 million USD |
| 2022 | 42.5 million USD | 409.9 million USD |
| 2021 | -100.9 million USD | 409.7 million USD |
| 2020 | -10.4 million USD | 331.5 million USD |
| 2019 | -17.0 million USD | 324.8 million USD |
PROC
Price: $2.62
52 week price:
Earnings Per Share: 0.51 USD
P/E Ratio: 6.08
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 18000
Market Capitalization: 303.5 million